VyGen-Bio (Two Technology Assets) is Buildings and Property in United States that focus on technology assets business. They cover business area such as two technology asset, cancer treatment, Florida, United States, an nk cell-base investigational therapeutic, combination therapy, side effect, an investigational, tool, cancer patient, monotherapy.
-
Technology Assets
-
Fowler Campus in University Park
4105 East Fowler Avenue
Tampa, FL 33617
United States
Private
two technology assetcancer treatmentFloridaUnited Statesan nk cell-base investigational therapeuticcombination therapyside effectan investigationaltoolcancer patientmonotherapy
* We use standard office opening hours in near VyGen-Bio (Two Technology Assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
VyGen-Bio (Two Technology Assets) is Buildings and Property business from United States that founded in - ( years old in ), VyGen-Bio (Two Technology Assets) business is focusing on Technology Assets.
VyGen-Bio (Two Technology Assets) headquarter office and corporate office address is located in Fowler Campus in University Park 4105 East Fowler Avenue Tampa, FL 33617 United States.
VyGen-Bio (Two Technology Assets) was founded in United States.
In , VyGen-Bio (Two Technology Assets) is currently focus on technology assets sector.
Above is snippet of Google Trends for "technology assets" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with VyGen-Bio (Two Technology Assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
